Broad-spectrum microbial cell components

This entry does not correspond to a singular, well-defined molecule, gene, or canonical therapeutic target but refers collectively to the structural and functional components present in a wide range of microbial cells that are eligible targets for broad-spectrum antibiotics or innate immune effectors. These include, but are not limited to, **peptidoglycan** (the principal component of bacterial cell walls, especially in Gram-positive organisms), **lipopolysaccharide** (LPS, a major outer membrane constituent of Gram-negative bacteria acting as endotoxin), **teichoic and lipoteichoic acids** (in Gram-positive bacteria), and the **extracellular polymeric matrix** of biofilms (containing polysaccharides, proteins, nucleic acids, and lipids)[1][2][3][4]. Many antibiotics (such as beta-lactams, glycopeptides, and membrane-active agents) and immune recognition molecules target these structures due to their conservation and essentiality for microbial viability. However, referring to this collection as a single "target" is imprecise; these are a set of structurally and functionally distinct components rather than a molecular entity.

Other names

microbial cell wall componentsbacterial cell envelope componentsmicrobial biofilm matrix constituentspathogen-associated molecular patterns (PAMPs) (when referring to immune recognition)broad-spectrum bacterial targets

Disrupt cell wall synthesis (e.g., beta-lactam inhibition of transpeptidase cross-linking)[1][6] Disrupt cytoplasmic membrane integrity (e.g., DCAP collapsing membrane potential, polymyxins targeting Gram-negative outer membrane)[5] Lyse cell wall or degrade structural components (e.g., lysozyme hydrolyzing peptidoglycan) Prevent biofilm matrix formation or disrupt established biofilms